SCHEMBL10196355

SCHEMBL10196355

COC(=O)c1ccc(C(c2ccc(-c3cnc(-n4c(C)ccc4C)nc3)cc2)C(C)(C)C)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 4/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR3 Q99500 1/20 0.36
ALDH1A1 P00352 2/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ACACB O00763 2/20 0.34
OGA O60502 2/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
ROCK2 O75116 1/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10196353 0.82 MAPK1 (0.37) MAPK1KDM4EL3MBTL1S1PR4S1PR3
SCHEMBL13262241 0.81 KDM4E (0.38) KDM4E
SCHEMBL13230132 0.77 ALOX5AP (0.45) MAPK1KDM4EL3MBTL1ALDH1A1PKM
SCHEMBL10196354 0.76 MKNK1 (0.51) MAPK1S1PR4S1PR3PIK3CA
SCHEMBL480272 0.69 PARP10 (0.49) KDM4EALDH1A1KMT2AMAPT
SCHEMBL179293 0.65 MAPK1 (0.61) MAPK1KDM4EL3MBTL1S1PR4S1PR3
SCHEMBL15994611 0.65 TDP1 (0.55) MAPK1KDM4EL3MBTL1ALDH1A1CA12
SCHEMBL22060648 0.64 MAPK1 (0.60) MAPK1KDM4EL3MBTL1S1PR4S1PR3
SCHEMBL6223602 0.64 MAPK1 (0.59) MAPK1KDM4EL3MBTL1S1PR4S1PR3
SCHEMBL796852 0.64 MAPK1 (0.59) MAPK1KDM4EL3MBTL1S1PR4S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440672-B2 Diphenyl substituted alkanes MERCK SHARP & DOHME CORP. (US) 2013-05-14 US disclosed
US-8440672-B2 Diphenyl substituted alkanes MERCK SHARP & DOHME CORP. (US) 2013-05-14 US disclosed
EP-2064204-B1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK SHARP & DOHME (US) 2012-02-01 EP disclosed
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-01 US disclosed
WO-2008030369-A1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK & CO., INC. (US) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B MAPK1 1844/4885KDM4E 2454/4885L3MBTL1 2429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.